CMRX trade ideas

Hatchetaxe

smart investors / Insiders are buying as well / year end tax loss harvesting is almost done and I believe biotechs will run fast in jan / feb

TRADING_as_a_BUSINESS Updated 

Now we just need some news to get dropped. Some positive ones, and we are ready to do.

Risk_is_yours Updated 

Good Technical ( Nice Breakout ) and Good Fundamental ( Good Result ) , So Target 2.90 , Duration 1 to 5 months.

MarketMoversReport

CMRX: Chimerix, Inc. 2022-08-29 10:45:00 Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox

RocketTickers

CMRX: Chimerix, Inc. 2021-11-04 07:00:00 Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma

rudcharts

Analysis- Daily chart- After long downtrend, price has been in sideways market between 1.24-3.38 for 638 days. After making a move to resistance on July2020, price fell and found support from 200 MA then working itself back to resistance and finally breaking out. After breakout of 40%, price pulled back but was supported by 10MA were it went on to make another...

RedHotStocks

Potential entry above $ 4.60 Target price $ 5.10

Prestonlehmann1

simple wedge formed in order to add onto my long term hold once we hopefully bounce off of the 3.26 fib level

ProjectSyndicate

before we kick start the update. your upvotes/subs are appreciated. Why get subbed to to me on Tradingview? -15+ years real live trading experience -TOP Author on TradingView -professional chart break downs -key levels -no junk on my charts -frequent updates -covering FX/crypto/US stocks -24/7 uptime so constant updates So without further due. Keep it...

DEXWireNews

DURHAM, N.C., April 29, 2020 (GLOBE NEWSWIRE) -- Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced the Company’s initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19 patients with acute lung injury (ALI). DSTAT is a glycosaminoglycan...

Prestonlehmann1

I am currently long term bullish on CMRX. I see much upside for them once they can get FDA approval. I have been adding shares at the supports I have listed. NASDAQ:CMRX

AcornWealthCorp

CMRX - Recent buying 2 new insider purchases at $1.50-$1.76. Looking to break 1.93. Momentum play with first target at 2.43. Stop signal 1.67.

InsiderFinancial

After breaking higher in early April on large volume, Chimerix Inc. (NASDAQ:CMRX) spent the next several weeks digesting/consolidating the move before breaking higher yet again last month (May) and in the process, recapturing its 200 DMA as evidenced in the Daily chart above. With the stock presently trading above all of its important moving averages (20/50/200...

kiwiktrader

CMRX - SHORT 2.45 based on 5min candle

kiwiktrader

Will be looking this to have a morning panic biggest gainers today however closed very high and very near high of day. The main thing that stands out to me is the afternoon breakout I say this has pushed to over extension I will be looking for the panic to play, no panic no play entry point near 2.45 short float not very high though 2.32% may be enough to set if...

meitshel Updated 

i like this set up due to risk reward ratio 09/23/2018 Phase 1 data due 23-26 September 2018 at European Society for Clinical Virology.

S_A Updated 

trippel tops could be formed but till then a ranging trade is ongoing. both Trippel bottom and Trend Support act as a low level support.

S_A Updated 

awaiting a bullish candle and break over the PNL level.. RSI is overbought but MACD has still more potential upp.. I will follow this these days.. Impressive earning as well..